VOLITIONRX LTD (VNRX) Form 8-K — Sep 2, 2026
VolitionRx disclosed that Lind Global Asset Management XII LLC, holder of roughly $9.9 million of its senior secured convertible notes, signed a waiver and consent on September 2, 2026 permitting the company to sell stock under its ATM agreement without the prior $10 million annual cap, and consented to any and all such sales as Permitted ATM Sales rather than Prohibited Transactions. The waiver retroactively eliminates Events of Default, acceleration rights, collateral foreclosure remedies and any accrued Mandatory Default Amounts arising from past above-cap ATM sales, and waives anti-dilution adjustments for ATM sales after August 28, 2026.
Key figures
- Debt Amount
- $9,900,000 combined convertible note principal ($7,500,000 2025 Note + $2,400,000 January 2026 Note)
- Warrant shares
- 651,042 (2025 Warrant) + 350,018 (2026 Warrant)
- Prior atm annual cap
- $10 million per calendar year (now unlimited)
- Note 2025 principal usd
- 7500000
- Note 2026 principal usd
- 2400000
- Atm proceeds to note repayment
- 20% of proceeds from ATM sales in excess of Exempted Securities
- Adjusted conversion price notes
- 0.44
- Adjusted exercise price warrants
- 0.572
Price after filing
Close on the filing date to close N calendar days later (from $0.38). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.